Kalvista Pharmaceuticals Stock Market Value
| KALV Stock | USD 9.33 0.01 0.11% |
| Symbol | Kalvista |
Kalvista Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kalvista Pharmaceuticals. If investors know Kalvista will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kalvista Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.57) | Revenue Per Share 0.214 | Quarterly Revenue Growth 0.307 | Return On Assets (0.54) | Return On Equity (0.91) |
The market value of Kalvista Pharmaceuticals is measured differently than its book value, which is the value of Kalvista that is recorded on the company's balance sheet. Investors also form their own opinion of Kalvista Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kalvista Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kalvista Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kalvista Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kalvista Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalvista Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalvista Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kalvista Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kalvista Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kalvista Pharmaceuticals.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Kalvista Pharmaceuticals on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Kalvista Pharmaceuticals or generate 0.0% return on investment in Kalvista Pharmaceuticals over 30 days. Kalvista Pharmaceuticals is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small m... More
Kalvista Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kalvista Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kalvista Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 31.7 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 5.82 |
Kalvista Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kalvista Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kalvista Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Kalvista Pharmaceuticals historical prices to predict the future Kalvista Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | (0.23) |
Kalvista Pharmaceuticals Backtested Returns
Kalvista Pharmaceuticals has Sharpe Ratio of -0.0906, which conveys that the firm had a -0.0906% return per unit of risk over the last 3 months. Kalvista Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kalvista Pharmaceuticals' Risk Adjusted Performance of (0.06), standard deviation of 4.62, and Mean Deviation of 3.22 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.79, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kalvista Pharmaceuticals will likely underperform. At this point, Kalvista Pharmaceuticals has a negative expected return of -0.43%. Please make sure to verify Kalvista Pharmaceuticals' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Kalvista Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.68 |
Good predictability
Kalvista Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Kalvista Pharmaceuticals time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kalvista Pharmaceuticals price movement. The serial correlation of 0.68 indicates that around 68.0% of current Kalvista Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.76 |
Kalvista Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Kalvista Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kalvista Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Kalvista Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Kalvista Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kalvista Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kalvista Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kalvista Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kalvista Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Kalvista Pharmaceuticals Lagged Returns
When evaluating Kalvista Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kalvista Pharmaceuticals stock have on its future price. Kalvista Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kalvista Pharmaceuticals autocorrelation shows the relationship between Kalvista Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Kalvista Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.